Thursday, June 25, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 870 of 1,261
  1. US 8450321

    6-(1H-indazol-6-yl)-N-[4-(morpholin-4-yl)phenyl]imidazo-[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitor

    GILEAD CONNECTICUT, INC. · Granted May 28, 2013 · Expires May 23, 2033

    granted
  2. US 8450332

    LIMK2 inhibitors, compositions comprising them, and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted May 28, 2013 · Expires May 23, 2033

    granted
  3. US 8449877

    Pharmaceutically purified intact bacterial minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted May 28, 2013 · Expires May 23, 2033

    granted
  4. US 8445445

    Method of promoting hair growth using FGFR4 extracellular domains

    Five Prime Therapeutics, Inc. · Granted May 21, 2013 · Expires May 16, 2033

    granted
  5. US 8445681

    Azaindazoles useful as inhibitors of kinases

    Vertex Pharmaceuticals Incorporated · Granted May 21, 2013 · Expires May 16, 2033

    granted
  6. US 8444612

    Self contained wound dressing apparatus

    Covidien LP · Granted May 21, 2013 · Expires May 16, 2033

    granted
  7. US 8444991

    Method of preparing an immunologically-active adjuvant-bound dried vaccine composition

    The Regents of the University of Colorado, a Body Corporate · Granted May 21, 2013 · Expires May 16, 2033

    granted
  8. US 8444996

    Multicomponent vaccine for malaria providing long-lasting immune responses against plasmodia

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 21, 2013 · Expires May 16, 2033

    granted
  9. US 8445044

    Food thickening agent, method for producing food thickening agent

    Kent Precision Foods Group, Inc. · Granted May 21, 2013 · Expires May 16, 2033

    granted
  10. US 8445665

    Therapeutic compositions

    Alnylam Pharmaceuticals, Inc. · Granted May 21, 2013 · Expires May 16, 2033

    granted
  11. US 8445254

    Regulated expression of antigen and/or regulated attentuation to enhance vaccine immunogenicity and/or safety

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted May 21, 2013 · Expires May 16, 2033

    granted
  12. US 8445245

    Mutant MT-SP1 proteases with altered substrate specificity or activity

    Catalyst Biosciences, Inc. · Granted May 21, 2013 · Expires May 16, 2033

    granted
  13. US 8445251

    Rationally-designed single-chain meganucleases with non-palindromic recognition sequences

    Precision BioSciences, Inc. · Granted May 21, 2013 · Expires May 16, 2033

    granted
  14. US 8445509

    Fused heterocyclic derivatives and use thereof

    Takeda Pharmaceutical Company Limited · Granted May 21, 2013 · Expires May 16, 2033

    granted
  15. US 8445696

    Synthetic methods for spiro-oxindole compounds

    Xenon Pharmaceuticals Inc. · Granted May 21, 2013 · Expires May 16, 2033

    granted
  16. US 8445658

    Proteins with repetitive bacterial-Ig-like (Big) domains present in Leptospira species

    THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted May 21, 2013 · Expires May 16, 2033

    granted
  17. US 8445485

    Prodrugs of 2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted May 21, 2013 · Expires May 16, 2033

    granted
  18. US 8445434

    IGF-1 fusion polypeptides and therapeutic uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted May 21, 2013 · Expires May 16, 2033

    granted
  19. US 8445491

    Wnt protein signalling inhibitors

    The Board of Regents of the University of Texas System · Granted May 21, 2013 · Expires May 16, 2033

    granted
  20. US 8445461

    Pharmaceutical composition for meniere's disease

    Setsuko Takeda · Granted May 21, 2013 · Expires May 16, 2033

    granted
  21. US 8445473

    Heteroaryl-substituted bicyclic Smac mimetics and the uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 21, 2013 · Expires May 16, 2033

    granted
  22. US 8445501

    Substituted 7-carboxamido-pyrrolo[3,2-d]pyrimidines

    TAKEDA GMBH · Granted May 21, 2013 · Expires May 16, 2033

    granted
  23. US 8445507

    Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases

    The Regents of the University of California · Granted May 21, 2013 · Expires May 16, 2033

    granted
  24. US 8445541

    Methods for concomitant administration of colchicine and a second active agent

    Takeda Pharmaceuticals U.S.A., Inc. · Granted May 21, 2013 · Expires May 16, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.